Related Experiment Video
Updated: Jun 22, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy
Oktay Bilgir1, Mehmet Calan, Ferda Bilgir
1Department of The Second Internal Medicine, Izmir Bozyaka Education and Research Hospital, Turkey. obilgir2001@yahoo.com
Abstract:
Gabapentin (GBP) is a drug which is frequently used in diabetic neuropathy. Common adverse effects of GBP include drowsiness, dizziness, ataxia, somnolence, and fatigue. Rhabdomyolysis is an extremely rare side effect of GBP. In this report we describe a case of GBP-induced rhabdomyolysis in a 63-year-old diabetic woman. She presented with severe muscle pain in her extremities, fatigue, decreased urine output and urine discoloration within 3 weeks after starting treatment with GBP (900 mg/day) for diabetic neuropathy. Laboratory tests revealed extreme elevations of muscle enzymes, increased creatinine and potassium levels. She required hemodialysis as a result of anuria. Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of GBP resulted in resolution of clinical and biochemical features of rhabdomyolysis.
Related Concept Videos
Diabetic Neuropathy
Diabetic Nephropathy
Diabetic Ketoacidosis ll: Pathophysiology
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Diabetic Ketoacidosis l: Introduction
Complications of Diabetes Mellitus